acid a phytate salt or an isomer or hydrolysate of phytic acid or phytate salt by the term isomer as used herein it is intended to include the various conformations of phytic acid as described hereinabove and the corresponding conformations of phytate salts the term salts is broadly intended to cover any of the various salts formed by the replacement of any or all of the available acidic protons of the phosphate groups with a counterion the counterion may be any pharmaceutically acceptable counterion such as sodium magnesium potassium zinc ferric ferrous and the like including organic counterions such as quaternary ammonium ions and ions of organic bases the present invention also includes the hydrolysates of phytic acid and phytate salts wherein one or more of the phosphate groups have been removed once administered into the digestive tract bloodstream the phytic acid or phytate salt may be hydrolyzed by digestive blood or cellular enzymes thereby removing one or more of the phosphate groups on the cyclohexane ring however it is contemplated to be within the scope of the invention that these hydrolysates of phytic acid and phytate salts may also be administered directly to the subject and therefore are within the scope of the present invention the hydrolysates of phytic acid and phytate salts may be prepared by partial acid or basic hydrolysis or by hydrolysis using enzymes prior to preparation of dosage forms for administration preferably the hydrolysates will be made in vivo by coadministering with phytic acid or phytate salt an enzyme which hydrolyzes phosphate groups such as 3 phytase 6 phytase or acid phosphatase the phytic.